Who Exports Ornidazole from India — 249 Suppliers Behind a $17.7M Market
India's ornidazole export market is supplied by 249 active exporters who collectively shipped $17.7M across 1,175 shipments. LINCOLN PHARMACEUTICALS LTD leads with a 29.5% market share, followed by MICRO LABS LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 64.3% of total export value, reflecting a concentrated market structure.
Top Ornidazole Exporters from India — Ranked by Export Value
LINCOLN PHARMACEUTICALS LTD is the leading ornidazole exporter from India, holding a 29.5% share of the $17.7M market across 1,175 shipments from 249 exporters. The top 5 suppliers — LINCOLN PHARMACEUTICALS LTD, MICRO LABS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, KUSUM HEALTHCARE PRIVATE LIMITED, BIOMATRIX HEALTHCARE PRIVATE LIMITED — collectively control 64.3% of total export value, indicating a moderately concentrated market. Individual shares are: LINCOLN PHARMACEUTICALS LTD (29.5%), MICRO LABS LIMITED (22.4%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (8.1%), KUSUM HEALTHCARE PRIVATE LIMITED (2.9%), BIOMATRIX HEALTHCARE PRIVATE LIMITED (1.5%).
Top Ornidazole Exporters from India
Ranked by export value · 249 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | LINCOLN PHARMACEUTICALS LTD ORNIDAZOLE TABLETS 500 MG (44OFLOXACIN, ORNIDAZOLE, CLOBETASOL PROPIOLEVOMAC OZ 10X10S 80 PAC | $5.2M | 5 | 29.5% |
| 2 | MICRO LABS LIMITED ORNILOX )ORNILOX ( (OFLOXACIN + ORNIDAZOLE TABLETORNILOX ( (ORNIDAZOLE 500MG & OFLOXACIN | $4.0M | 15 | 22.4% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ORNIDAZOLE TABLETS 500 MG (44DAZOLIC TABS.ORNILOX | $1.4M | 7 | 8.1% |
| 4 | KUSUM HEALTHCARE PRIVATE LIMITED ORNIDAZOLE TABLETS 500 MG (44ORNILOX )ORNILOX ( (OFLOXACIN + ORNIDAZOLE TABLET | $504.7K | 11 | 2.9% |
| 5 | BIOMATRIX HEALTHCARE PRIVATE LIMITED ORNIDAZOLE TABLETS 500 MG (44DAZOLIC TABLETS PACK: BOX10X10S BATCH: JMF1480AORGYL-500 TABLETS 1X10S (ORNIDAZOLE 500 | $257.4K | 4 | 1.5% |
| 6 | CACHET PHARMACEUTICALS PRIVATE LIMITED ORNILOX )OFLOXACIN, ORNIDAZOLE, CLOBETASOL PROPIOORNILOX ( (OFLOXACIN + ORNIDAZOLE TABLET | $252.6K | 7 | 1.4% |
| 7 | AURA PHARMACEUTICALS PRIVATE LIMITED ORNIDAZOLE TABLETS 500 MG (44ORNILOXORNILOX ( (OFLOXACIN + ORNIDAZOLE TABLET | $222.1K | 5 | 1.3% |
| 8 | MEDEOR LIFE CARE LLP ORNILOX )ORNILOX ( (OFLOXACIN + ORNIDAZOLE TABLETORNILOX (ORNIDAZOLE 500MG + OFLOXACIN 20 | $220.9K | 2 | 1.3% |
| 9 | MACLEODS PHARMACEUTICALS LTD OFLOXACIN, ORNIDAZOLE, CLOBETASOL PROPIOORNILOX )ORNILOX ( (OFLOXACIN + ORNIDAZOLE TABLET | $220.2K | 2 | 1.2% |
| 10 | AUROCHEM PHARMACEUTICALS (INDIA) PRIVATELIMITED ORNILOX )ORNILOX ( (OFLOXACIN + ORNIDAZOLE TABLETORNILOX (ORNIDAZOLE 500MG + OFLOXACIN 20 | $215.0K | 1 | 1.2% |
| 11 | NV REMEDIES PRIVATE LIMITED | $185.5K | 1 | 1.0% |
| 12 | MICRO LABS LTD ORNILOX )ORNILOX ( (OFLOXACIN + ORNIDAZOLE TABLETORNILOX ( (ORNIDAZOLE 500MG & OFLOXACIN | $183.6K | 5 | 1.0% |
| 13 | PANACEA BIOTEC PHARMA LIMITED DAZOLIC TABS.ORNILOXDAZOLIC TABSPA | $181.0K | 5 | 1.0% |
| 14 | IND SWIFT LIMITED ORNIDAZOLE TABLETS 500 MG (44OFLOXACIN, ORNIDAZOLE, CLOBETASOL PROPIOORNILOX ) | $172.3K | 2 | 1.0% |
| 15 | SIMPEX PHARMA PRIVATE LIMITED | $156.2K | 2 | 0.9% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Ornidazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Lincoln Pharmaceuticals Limited | Not Listed | Yes, certified in 19 | Yes, certified | Not verified | WHO-GMP certified in 1984; EU GMP certification obtained in May 2020. |
| Micro Labs Limited | Not Listed | Yes, certified in Au | Yes | Not verified | WHO-GMP certified in August 2024; EU GMP certification status confirmed. (extran |
| Sun Pharmaceutical Industries Limited | Not Listed | Yes | Yes | Not verified | WHO-GMP and EU GMP certifications confirmed. |
| Macleods Pharmaceuticals Ltd | Not Listed | Yes | Yes | Not verified | WHO-GMP and EU GMP certifications confirmed. |
| Aurobindo Pharma Ltd | Not Listed | Yes | Yes | Not verified | WHO-GMP and EU GMP certifications confirmed. |
| Cipla Ltd | Not Listed | Yes | Yes | Not verified | WHO-GMP and EU GMP certifications confirmed. |
| Lupin Ltd | Not Listed | Yes | Yes | Not verified | WHO-GMP and EU GMP certifications confirmed. |
| Hetero Labs Ltd | Not Listed | Yes | Yes | Not verified | WHO-GMP and EU GMP certifications confirmed. |
TransData Nexus reviewed the regulatory standing of 8 leading Ornidazole exporters from India. 0 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Ornidazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," hosts over 800 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The city's Genome Valley is India's first biotech cluster, fostering advanced R&D infrastructure and a skilled talent pool. This robust ecosystem makes Hyderabad a strategic location for sourcing Active Pharmaceutical Ingredients (APIs) like Ornidazole.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat contributes nearly 28% of India's pharmaceutical production. Home to companies such as Zydus Cadila and Torrent Pharmaceuticals, this region is renowned for its strong support infrastructure, including ports and transportation networks. Its focus on formulations positions it as a key area for sourcing finished Ornidazole products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a pivotal export gateway for pharmaceuticals. With 929 pharmaceutical units, the region offers proximity to major ports, facilitating efficient international distribution. This strategic location enhances the export capabilities of Ornidazole manufacturers operating in the area.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, is India's largest pharmaceutical manufacturing hub by volume, housing over 1,000 pharma units. The region's growth has been bolstered by favorable government policies and tax incentives, attracting numerous manufacturers. This makes Baddi a significant zone for sourcing Ornidazole, especially for cost-effective production.
5Sourcing Recommendations
- Diversify Supplier Base: While the top five exporters dominate 64.3% of Ornidazole exports, engaging with a broader range of suppliers can mitigate risks and enhance supply chain resilience.
- Leverage Regional Strengths: Utilize Hyderabad for API sourcing, Ahmedabad-Vadodara for formulations, and Mumbai-Thane-Raigad for export logistics to optimize the supply chain.
- Evaluate Cost Benefits: Consider sourcing from Baddi-Nalagarh to take advantage of tax incentives and potentially lower production costs.
- Monitor Export Trends: Keep track of key export destinations like Tanzania and France to align production and distribution strategies with market demands.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Ornidazole exporters from India
Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals for $347.73 million
Sun Pharma, the controlling shareholder of Taro Pharmaceuticals, announced a definitive merger agreement to acquire all outstanding shares of its subsidiary for $347.73 million. IMPACT: This acquisition is expected to enhance Sun Pharma's global market presence, potentially increasing its Ornidazole export capabilities.
Impact: This acquisition is expected to enhance Sun Pharma's global market presence, potentially increasing its Ornidazole export capabilities.
Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million
Sun Pharma announced the acquisition of Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology treatments, for $355 million. IMPACT: While primarily focused on oncology, this acquisition may lead to expanded research and development resources, indirectly benefiting Ornidazole production and exports.
Impact: While primarily focused on oncology, this acquisition may lead to expanded research and development resources, indirectly benefiting Ornidazole production and exports.
Lincoln Pharmaceuticals Limited — Lincoln Pharma expands Mehsana facility, begins commercial production
Lincoln Pharmaceuticals completed the expansion of its Cephalosporin manufacturing facility in Mehsana, Gujarat, and commenced commercial production, with initial sales in the domestic market. IMPACT: This expansion may enhance Lincoln Pharmaceuticals' overall production capacity, potentially increasing Ornidazole exports.
Impact: This expansion may enhance Lincoln Pharmaceuticals' overall production capacity, potentially increasing Ornidazole exports.
Common Questions — Ornidazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which ornidazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, LINCOLN PHARMACEUTICALS LTD leads with 14 recorded shipments worth $5.2M. MICRO LABS LIMITED (181 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (30 shipments) are also established high-volume exporters.
Q How many ornidazole manufacturers are there in India?
India has 249 active ornidazole exporters with a combined export market of $17.7M across 1,175 shipments to 83 countries. The top 5 suppliers hold 64.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for ornidazole from India?
Average FOB unit price: $4.25 per unit, ranging from $0.00 to $255.97. Average shipment value: $15.0K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 249 verified Indian exporters of Ornidazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,175 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 83 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,175 Verified Shipments
249 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists